‘ … they just take one pill, so it is easy to use, more convenient … ’ : South African health care provider perspectives on a Dual Prevention Pill

作者：Sanyukta Mathur, Siyanda Tenza, Lorna Begg, Lydia Mampuru, Irene V. Bruce, Mpho Moji, Nkosiphile Ndlovu, Krishnaveni Reddy, Thesla Palanee-Phillips, Barbara Friedland · 发表于：SAHARA-J Journal of Social Aspects of HIV/AIDS · 年份：2026 · DOI：10.1080/17290376.2026.2678165 · 研究领域：HIV/AIDS Research and Interventions、Reproductive Health and Contraception、Adolescent Sexual and Reproductive Health

The Dual Prevention Pill (DPP) is a daily oral pill containing oral pre-exposure prophylaxis (PrEP) for protection against HIV and a combined oral contraceptive (COC) for the prevention of unintended pregnancy, currently under development. However, little is known about healthcare providers' (HCPs) perspectives on this potential new multipurpose prevention technology (MPT). A more granular understanding of HCP views about the DPP may support efforts to ensure equitable introduction of and access to this innovative technology. We conducted in-depth interviews with 17 HCPs working at family planning (FP) and HIV service sites in Johannesburg, South Africa. We used a qualitative framework analysis to examine HCP perspectives on potential end-users, the DPP concept and health system-related considerations. HCPs articulated that the DPP would meet the needs of their clients, contribute to more efficient and effective integrated sexual and reproductive health service delivery and meet broader community goals for the reduction in HIV infections and unintended pregnancies. HCPs noted concerns and potential challenges with the product's daily dosing regimen, potential for exacerbated side effects (compared to oral PrEP or COCs taken alone) and potential ethical considerations about offering the DPP to adolescents. HCPs felt the DPP should be available through public health care facilities to maximise outreach and ensure appropriate care, and discussed community-based delivery options ...